focal segmental glomerulosclerosis
focal segmental glomerulosclerosis
Explore linked clinical trials. Standard reference: MONDO:010031339 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, autoimmune disease, focal segmental glomerulosclerosis, glomerulonephritis, immune system disorder, kidney disorder, macular corneal dystrophy, membranous glomerulonephritis, minimal change disease, nephritis, nephrosis, proteinuria, urinary system disorder | Recruiting | Phase 2 | 2026-10-09 | NCT06664814 | |
| A Study to Evaluate the Effectiveness and Safety of Sibeprenlimab in Participants With Primary Membranous Nephropathy, Immune-mediated Focal Segmental Glomerulosclerosis, and Minimal Change Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, minimal change disease, nephritis, nephrosis, urinary system disorder | Not yet recruiting | Phase 2 | 2026-10-06 | NCT07861113 | |
| A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS) | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, kidney failure, nephritis, proteinuria, urinary system disorder | Recruiting | Phase 2 | 2026-10-01 | NCT07268638 | |
| A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, urinary system disorder | Recruiting | Phase 3 | 2026-09-30 | NCT07220083 | |
| A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, minimal change disease, nephritis, nephrosis, urinary system disorder | Recruiting | Phase 2 | 2026-09-23 | NCT06500702 | |
| A Study to Evaluate the Safety, Tolerability and PK of SK-09 | focal segmental glomerulosclerosis, macular corneal dystrophy | Recruiting | Phase 1 | 2026-09-03 | NCT07267026 | |
| A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis | focal segmental glomerulosclerosis | Recruiting | Phase 2 / Phase 3 | 2026-09-02 | NCT07213960 | |
| Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, urinary system disorder | Recruiting | Not applicable | 2026-08-28 | NCT04065438 | |
| Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, urinary system disorder | Recruiting | Not applicable | 2026-08-28 | NCT02235857 | |
| Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, focal segmental glomerulosclerosis, glomerulonephritis, immune system disorder, kidney disorder, minimal change disease, nephritis, nephrosis, urinary system disorder | Recruiting | Phase 2 | 2026-08-05 | NCT07614477 | |
| Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyalinosis, Segmental Glomerular, IgA glomerulonephritis, Male Urogenital Diseases, Nephrotic Syndrome, Minimal Change, Skin and Connective Tissue Diseases, Urogenital Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, diabetes mellitus, diabetic kidney disease, endocrine system disorder, focal segmental glomerulosclerosis, glomerulonephritis, immune system disorder, interstitial nephritis, kidney disorder, membranous glomerulonephritis, minimal change disease, necrotizing vasculitis, nephritis, nephrosis, skin disorder, skin vascular disease, urinary system disorder, vascular disorder, vasculitis | Recruiting | Not stated | 2026-06-30 | NCT07010250 | |
| Atacicept in Multiple Glomerular Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, focal segmental glomerulosclerosis, glomerulonephritis, immune system disorder, kidney disorder, macular corneal dystrophy, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Phase 2 | 2026-06-26 | NCT06983028 | |
| Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, proteinuria, urinary system disorder | Active, not recruiting | Phase 4 | 2026-06-23 | NCT07219121 | |
| Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, kidney failure, minimal change disease, nephritis, nephrosis, nephrotic syndrome, proteinuria, urinary system disorder | Active, not recruiting | Not stated | 2026-06-11 | NCT02194582 | |
| NEPTUNE Match Study | Alport syndrome, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nephrotic Syndrome, Minimal Change, Skin and Connective Tissue Diseases, Urogenital Abnormalities, Urogenital Diseases, autoimmune disease, connective tissue disorder, focal segmental glomerulosclerosis, glomerulonephritis, hereditary nephritis, immune system disorder, kidney disorder, macular corneal dystrophy, membranous glomerulonephritis, minimal change disease, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not applicable | 2026-06-10 | NCT04571658 | |
| Nephrotic Syndrome Study Network | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, focal segmental glomerulosclerosis, glomerulonephritis, immune system disorder, kidney disorder, macular corneal dystrophy, membranous glomerulonephritis, minimal change disease, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not stated | 2026-06-10 | NCT01209000 | |
| Atrasentan in Patients With Proteinuric Glomerular Diseases | Alport syndrome, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Abnormalities, Urogenital Diseases, autoimmune disease, connective tissue disorder, diabetes mellitus, diabetic kidney disease, endocrine system disorder, focal segmental glomerulosclerosis, glomerulonephritis, hereditary nephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Active, not recruiting | Phase 2 | 2026-06-01 | NCT04573920 | |
| Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases | Alport syndrome, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Hemorrhage, IgA glomerulonephritis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Urogenital Abnormalities, Urogenital Diseases, autoimmune disease, blood coagulation disease, cardiovascular disorder, connective tissue disorder, focal segmental glomerulosclerosis, glomerulonephritis, hematologic disorder, hemorrhagic disease, hereditary nephritis, immune system disorder, immunoglobulin A vasculitis, kidney disorder, macular corneal dystrophy, minimal change disease, nephritis, nephrosis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, urinary system disorder, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Phase 2 | 2026-05-12 | NCT05003986 | |
| REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nephrotic Syndrome, Minimal Change, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, minimal change disease, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Active, not recruiting | Phase 3 | 2026-05-11 | NCT06635720 | |
| Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, macular corneal dystrophy, minimal change disease, nephritis, nephrosis, urinary system disorder | Recruiting | Not stated | 2026-04-29 | NCT05650619 | |
| A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, minimal change disease, nephritis, nephrosis, urinary system disorder | Recruiting | Not applicable | 2026-04-17 | NCT05583942 | |
| taVNS for FRNS in Children | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, minimal change disease, nephritis, nephrosis, urinary system disorder | Recruiting | Not applicable | 2026-04-15 | NCT05588063 | |
| SLIT ABS: Study on Patients With Autoimmune Podocytopathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nephrotic Syndrome, Minimal Change, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, disease, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, minimal change disease, nephritis, nephrosis, urinary system disorder | Recruiting | Not applicable | 2026-04-08 | NCT07516964 | |
| A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, minimal change disease, nephritis, nephrosis, urinary system disorder | Recruiting | Phase 2 / Phase 3 | 2026-04-03 | NCT07499700 | |
| INS, B Cells and Microbiota | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, glomerulosclerosis, kidney disorder, minimal change disease, nephritis, nephrosis, urinary system disorder | Recruiting | Not stated | 2026-03-03 | NCT04924712 |